Nasopharyngeal carcinoma Information
 |
+852 2788 2128 |
 |
info@amo-oncology.com.hk |
 |
Room 1311-1312, 13/F, Ocean Center, Harbour City, 5 Canton Road, Tsim Sha Tsui |
 |
Room 1311-1312, 13/F, Ocean Center, Harbour City, 5 Canton Road, Tsim Sha Tsui |
Nasopharyngeal carcinoma Treatment
Nasopharyngeal carcinoma is a malignant tumor that occurs in the nasopharynx or upper throat. It is more common in southern China. Genetic factor is currently considered the main cause. Nasopharyngeal carcinoma is mainly classified into keratinizing squamous cell carcinoma, non-keratinizing squamous cell carcinoma and undifferentiated carcinoma at the microscopic level. Moreover, early-stage nasopharyngeal tumors are generally hidden beneath the mucous membrane of nasopharynx and thus difficult to detect.
Radiotherapy
Radiotherapy can be classified into palliative and radical. The former is more suitable for terminal patients as the tumor may be insensitive to radiation, or the patient's physical condition is unable to withstand radical radiotherapy; the latter is suitable for stage I-III patients. However, this treatment may cause some side effects, such as dry mouth, tooth sensitivity to cold and heat, subcutaneous edema on the face and neck, radiation-induced otitis media, etc.
Chemotherapy
Mostly used as adjuvant or palliative therapy, chemotherapy can lengthen the life expectancy of patients. Medication can be applied through systemic or superficial temporal artery intubation chemotherapy.
Surgical excision
The cancerous part of the nasopharynx can be removed surgically. It is only suitable for patients with recurrent nasopharyngeal neoplasms after radiotherapy, and is only a remedial measure to lengthen the life expectancy of patients.
Reference
- 泰山公德會, 鼻咽癌, http://www.taishan-international.org/407632169330284.html
